PDCD5, Caspase-3 expression in advanced NSCLC significance and sensitivity to platinum-based chemotherapy

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-13003633

Enrollment

Unknown

Registered

2013-09-26

Start date

2013-10-31

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non small cell lung cancer

Interventions

observation:chemotherapy

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Liver and kidney function is normal

Exclusion criteria

Exclusion criteria: Liver and kidney function is abnormal

Design outcomes

Primary

Measure	Time frame
Protein content;	—

Countries

China

Contacts

Public ContactPing Gong

lhgp832000@sina.com+86 0993 2012389

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026